Biolase - 15 Year Stock Price History | BIOLQ
Historical daily share price chart and data for Biolase since 2011 adjusted for splits and dividends. The latest closing stock price for Biolase as of June 16, 2026 is 0.00.
- The all-time high Biolase stock closing price was 72509.50 on April 26, 2013.
- The Biolase 52-week high stock price is 0.01, which is % above the current share price.
- The Biolase 52-week low stock price is 0.00, which is % below the current share price.
- The average Biolase stock price for the last 52 weeks is 0.00.
| Biolase Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 0.0001 | 0.0002 | 0.0002 | 0.0001 | 0.0001 | -50.00% |
| 2025 | 0.0056 | 0.0080 | 0.0150 | 0.0001 | 0.0002 | -98.33% |
| 2024 | 0.1751 | 1.1000 | 1.1300 | 0.0040 | 0.0120 | -98.93% |
| 2023 | 17.9126 | 71.0000 | 75.0000 | 1.0900 | 1.1200 | -98.28% |
| 2022 | 501.6494 | 1050.0000 | 1100.0000 | 59.0000 | 65.0000 | -93.33% |
| 2021 | 1794.7421 | 1175.0000 | 3750.0000 | 950.0000 | 975.0000 | -7.14% |
| 2020 | 1094.3676 | 1525.0000 | 2175.0000 | 575.0000 | 1050.0000 | -23.64% |
| 2019 | 3605.2579 | 2600.0000 | 6950.0000 | 1175.0000 | 1375.0000 | -44.44% |
| 2018 | 4142.8287 | 5250.0000 | 6625.0000 | 2300.0000 | 2475.0000 | -53.95% |
| 2017 | 12137.4502 | 18375.0000 | 21250.0000 | 4875.0000 | 5375.0000 | -69.29% |
| 2016 | 16519.8413 | 11125.0000 | 24125.0000 | 9375.0000 | 17500.0000 | 66.67% |
| 2015 | 20445.4365 | 33000.0000 | 34125.0000 | 7750.0000 | 10500.0000 | -68.06% |
| 2014 | 29947.7230 | 33830.8000 | 41791.0000 | 22000.0000 | 32875.0000 | -6.60% |
| 2013 | 38329.8075 | 22989.8000 | 72509.5000 | 14806.7000 | 35199.0000 | 55.59% |
| 2012 | 26805.9432 | 32245.2000 | 40636.1000 | 18887.3000 | 22622.9000 | -26.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.000B | $0.049B |
| Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |